Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tilman M Hackeng

Showing results (61-70 of 141) with videos related to

Pageof 15
Sort By:
Contrast Media & Molecular Imaging|December 6, 2017
Use of Cyclic Backbone NGR-Based SPECT to Increase Efficacy of Postmyocardial Infarction Angiogenesis ImagingGeert Hendrikx, Tilman M Hackeng, Rick van Gorp, et al.
Haematologica|April 10, 2010
Similar hypercoagulable state and thrombosis risk in type I and type III protein S-deficient individuals from mixed type I/III familiesElisabetta Castoldi, Lisbeth F A Maurissen, Daniela Tormene, et al.
Blood|October 2, 2004
Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endotheliumPhilipp von Hundelshausen, Rory R Koenen, Markus Sack, et al.
Research and Practice in Thrombosis and Haemostasis|February 4, 2021
Inhibition of platelet adhesion, thrombus formation, and fibrin formation by a potent αIIbβ3 integrin inhibitor from ticksDanique L van den Kerkhof, Magdolna Nagy, Kanin Wichapong, et al.
Thrombosis Research|August 4, 2022
Unraveling the role of the homoarginine residue in antiplatelet drug eptifibatide in binding to the αIIbβ3 integrin receptorDanique L van den Kerkhof, Magdolna Nagy, Kanin Wichapong, et al.
The Journal of Biological Chemistry|June 26, 2019
Tick saliva protein Evasin-3 modulates chemotaxis by disrupting CXCL8 interactions with glycosaminoglycans and CXCR2Stepan S Denisov, Johannes H Ippel, Alexandra C A Heinzmann, et al.
Blood|December 28, 2007
Re-evaluation of the role of the protein S-C4b binding protein complex in activated protein C-catalyzed factor Va-inactivationLisbeth F A Maurissen, M Christella L G D Thomassen, Gerry A F Nicolaes, et al.
Blood|January 8, 2015
Characterization of an autosomal dominant bleeding disorder caused by a thrombomodulin mutationYesim Dargaud, Jean Yves Scoazec, Simone J H Wielders, et al.
Journal of Thrombosis and Haemostasis : JTH|January 30, 2023
Protein arginine deiminase 4 inactivates tissue factor pathway inhibitor-alpha by enzymatic modification of functional arginine residuesM Christella L G D Thomassen, Bryan R C Bouwens, Kanin Wichapong, et al.
Organic Letters|December 21, 2004
Design and synthesis of a bimodal target-specific contrast agent for angiogenesisAnouk Dirksen, Sander Langereis, Bas F M de Waal, et al.
Pageof 15

Showing results (61-70 of 141) with videos related to

Sort By:
Pageof 15
Contrast Media & Molecular Imaging|December 6, 2017
Use of Cyclic Backbone NGR-Based SPECT to Increase Efficacy of Postmyocardial Infarction Angiogenesis ImagingGeert Hendrikx, Tilman M Hackeng, Rick van Gorp, et al.
Haematologica|April 10, 2010
Similar hypercoagulable state and thrombosis risk in type I and type III protein S-deficient individuals from mixed type I/III familiesElisabetta Castoldi, Lisbeth F A Maurissen, Daniela Tormene, et al.
Blood|October 2, 2004
Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endotheliumPhilipp von Hundelshausen, Rory R Koenen, Markus Sack, et al.
Research and Practice in Thrombosis and Haemostasis|February 4, 2021
Inhibition of platelet adhesion, thrombus formation, and fibrin formation by a potent αIIbβ3 integrin inhibitor from ticksDanique L van den Kerkhof, Magdolna Nagy, Kanin Wichapong, et al.
Thrombosis Research|August 4, 2022
Unraveling the role of the homoarginine residue in antiplatelet drug eptifibatide in binding to the αIIbβ3 integrin receptorDanique L van den Kerkhof, Magdolna Nagy, Kanin Wichapong, et al.
The Journal of Biological Chemistry|June 26, 2019
Tick saliva protein Evasin-3 modulates chemotaxis by disrupting CXCL8 interactions with glycosaminoglycans and CXCR2Stepan S Denisov, Johannes H Ippel, Alexandra C A Heinzmann, et al.
Blood|December 28, 2007
Re-evaluation of the role of the protein S-C4b binding protein complex in activated protein C-catalyzed factor Va-inactivationLisbeth F A Maurissen, M Christella L G D Thomassen, Gerry A F Nicolaes, et al.
Blood|January 8, 2015
Characterization of an autosomal dominant bleeding disorder caused by a thrombomodulin mutationYesim Dargaud, Jean Yves Scoazec, Simone J H Wielders, et al.
Journal of Thrombosis and Haemostasis : JTH|January 30, 2023
Protein arginine deiminase 4 inactivates tissue factor pathway inhibitor-alpha by enzymatic modification of functional arginine residuesM Christella L G D Thomassen, Bryan R C Bouwens, Kanin Wichapong, et al.
Organic Letters|December 21, 2004
Design and synthesis of a bimodal target-specific contrast agent for angiogenesisAnouk Dirksen, Sander Langereis, Bas F M de Waal, et al.
Pageof 15